Lee’s Pharmaceutical Holdings Limited has dispatched a circular convening its annual general meeting (AGM) for 11:00 a.m. on 21 May 2026 at Hong Kong Science Park. Key items to be tabled are outlined below.

1. Capital Management Proposals • Repurchase Mandate: Directors seek authority to repurchase up to 10% of the issued share capital—58.88 million shares—based on the 588.84 million shares outstanding as at 16 April 2026. • Issue Mandate: A separate resolution will allow the Board to issue new shares or convertible securities up to 20% of current issued capital, equivalent to 117.77 million shares. • Extension: The number of shares actually repurchased, if any, may be added to the fresh issuance limit. • Funding Impact: Management notes that exercising the full buy-back could materially affect working capital and gearing; repurchases will be executed only when financial conditions permit and public float remains above 25%.

2. Board Composition • Re-election: Three directors—Executive Chair Ms. Lee Siu Fong, Non-executive Director Dr. Li Xiaoyi, and Independent Non-executive Director Dr. Chan Yau Ching (serving since 2002)—will retire and offer themselves for re-election. The Nomination Committee confirms their continued suitability and independence. • Independence Review: Despite Dr. Chan’s tenure exceeding nine years, the Board views him as independent under Listing Rule 3.13.

3. Shareholding Structure and Takeovers Code • A concerted group comprising Huby Technology Limited and related parties controls 182.17 million shares, or 30.94% of the company. Full exercise of the buy-back mandate would raise this stake to 34.38%, potentially triggering a mandatory offer under the Takeovers Code. The Board states it has no present intention to repurchase shares to that extent.

4. Dividend Proposal • Shareholders will vote on a final dividend for the year ended 31 December 2025; the circular does not disclose the proposed amount.

5. Timetable Highlights • Register Closure for AGM: 18–21 May 2026 (both days inclusive). • Register Closure for Final Dividend: 29 May–1 June 2026 (both days inclusive).

6. Historical Share Price Range (Apr 2025–Apr 2026) • 12-month high: HK$2.70 (Sep 2025) • 12-month low: HK$1.17 (Apr 2026)

Proxy forms must be lodged with Computershare Hong Kong Investor Services Limited no later than 48 hours before the AGM. All resolutions will be decided by poll.